Latest Market News

Coventry Group Limited has appointed Nik Alpert as Acting Group CEO, while announcing the retirement of CFO Rod Jackson and the upcoming appointment of Patrick Maloney as his successor.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart stem cell technology, setting the stage for a focused clinical push in treating fistulising Crohn’s disease. The company also refreshed its board and raised $7.5 million to support this next phase.

SportsHero has launched its iGV Family Game Pass in partnership with Indonesia’s second-largest telco, Indosat, offering gamers access to over 200 popular PC titles via direct carrier billing.

Iltani Resources has successfully closed a Share Purchase Plan raising $965,000 and secured an additional $200,000 via a private placement, bringing total recent capital raised to nearly $3 million. These funds will fuel exploration at its promising Orient Silver-Indium Project and other ventures.

BWP Trust proposes to internalise its management by acquiring BWPM from Wesfarmers for $142.6 million, restructure 62 Bunnings leases to extend lease terms and options, and commit $86 million to capital upgrades. The transaction is forecast to be accretive to FY2026 distributions and requires investor approval.

BWP Trust and Wesfarmers have agreed on a transformative $142.6 million transaction involving management internalisation, lease extensions with Bunnings, and capital commitments to upgrade stores, aiming to boost income certainty and distribution growth.

Whitebark Energy has finalized a preliminary well design and rig market assessment for drilling the massive Rickerscote prospect in 2026, estimating costs at AU$7.7 million. The move positions the company at the forefront of Australia's emerging hydrogen, helium, and hydrocarbon sectors.

Following its merger with IDM International, Blackstone Minerals announces key board and management changes to spearhead development of the Mankayan Copper-Gold Project in the Philippines.

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.

Orthocell has marked a pivotal milestone with the first US surgical use of its Remplir™ nerve repair device following FDA clearance, setting the stage for commercial expansion in a $1.6 billion market.

Mandalay Resources Corporation has agreed to a plan of arrangement to be acquired by Alkane Resources Limited through its wholly owned subsidiary. Mandalay shareholders will receive 7.875 Alkane shares for each Mandalay share held, creating a combined gold and antimony producer with a strong balance sheet and diversified operations across Australia and Sweden.

Riedel Resources Limited has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a 7.4% discount, aiming to raise up to A$300,000 to fund exploration activities at its Kingsman Project in Arizona.